Testosterone Replacement Therapy and Cardiovascular Events | Zendy

Alp Burak Çatakoğlu | Zendy; Muammer Kendirci | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Testosterone Replacement Therapy and Cardiovascular Events

Author(s) -

Alp Burak Çatakoğlu,

Muammer Kendirci

Publication year - 2017

Publication title -

turk kardiyoloji dernegi arsivi-archives of the turkish society of cardiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.2

H-Index - 24

ISSN - 1016-5169

DOI - 10.5543/tkda.2017.00531

Subject(s) - testosterone (patch) , testosterone replacement , medicine , disease , adverse effect , cardiovascular health , obesity , medical prescription , endocrinology , intensive care medicine , androgen , pharmacology , hormone

A low testosterone level and hypogonadism are associated with cardiovascular disease. Aging, chronic health problems, and obesity are all associated with a low testosterone level as well as the presence and severity of cardiovascular disease. Testosterone is increasingly prescribed for patients with clinical hypogonadism and a low testosterone level. The information we have is still contradictory regarding testosterone replacement therapy (TRT) and its association with adverse cardiovascular events. Older patients and patients who are susceptible to cardiovascular diseases could be at risk with a testosterone prescription. This is a review of the literature to discuss the cardiovascular safety of TRT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research